糖尿病多支病变血运重建的真实世界转诊模式与结局:MULTICAD登记研究
基于以色列MULTICAD前瞻性登记,分析475例糖尿病合并多支和/或左主干病变患者的血运重建转诊模式与结局,48%接受外科、52%接受经皮血运重建。左主干狭窄和高Syntax评分与外科转诊独立相关,高龄、既往PCI和肾功能不全是经皮转诊的独立相关因素。7个月时两组死亡风险无差异,7个月后外科血运重建与显著生存获益相关。
要点
- 糖尿病多支病变真实世界中仅约半数转诊外科血运重建。
- 左主干狭窄和高Syntax评分与外科转诊独立相关。
- 7个月后外科较经皮血运重建与显著生存获益相关。
核心结论
- 真实世界中仅约半数糖尿病多支病变患者转诊外科血运重建,尽管指南有相应指征。
- 外科较经皮血运重建与改善的长期生存相关,该获益在血运重建术后7个月后显现。
研究设计与样本
- 研究使用MULTICAD以色列前瞻性登记数据,纳入475例糖尿病合并多支和/或左主干病变患者。
- 采用描述性统计、Kaplan-Meier、Cox和logistic回归分析转诊模式、短期结局和长期生存。
主要发现
- 475例中48%接受外科血运重建,52%接受经皮血运重建。
- 左主干狭窄(OR 1.89;P=0.030)和高Syntax评分(每增加1分OR 1.15;P<0.001)与外科转诊独立相关。
- 高龄(每增1岁OR 1.03;P=0.019)、既往PCI(OR 1.83;P=0.009)和肾功能不全(OR 2;P=0.026)与经皮血运重建转诊相关。
- 随访7个月时,外科与经皮血运重建组死亡风险无差异(HR 1.23,95%CI 0.5-3.04;P=0.649)。
- 7个月后,外科血运重建与显著生存获益相关(HR 2.24,95%CI 1.03-4.87;P=0.042)。
临床怎么用
- 对糖尿病合并多支病变患者,应评估左主干狭窄和Syntax评分以指导血运重建方式选择。
- 高龄、既往PCI和肾功能不全患者更倾向接受经皮血运重建,需个体化评估。
- 外科血运重建的生存获益在7个月后显现,决策时应考虑长期获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Diabetes mellitus patients with multivessel coronary artery disease present with a poor prognosis. We aimed to explore real-life clinical outcomes of diabetic patients who were referred for coronary revascularization. METHODS: We used data from the Multi-vessel Coronary Artery Disease (MULTICAD) Israeli Registry. Using descriptive statistics, Kaplan-Meier, Cox and logistic regression, we described a revascularization referral pattern, short-term outcomes and long-term survival among 475 diabetic patients with multivessel and/or left main disease, 48% of whom underwent surgical and 52% percutaneous revascularization. RESULTS: Factors independently associated with referral for surgery included the presence of left main stenosis [odds ratio (OR) 1.89; P = 0.030] and a higher Syntax score (OR 1.15 per point increment; P < 0.001), whereas an older age (OR 1.03 per 1-year increment in age; P = 0.019), prior percutaneous coronary intervention (OR 1.83; P = 0.009) and the presence of renal impairment (OR 2; P = 0.026) were associated with percutaneous coronary intervention referral. At 7 months of follow-up, multivariable analysis did not reveal any difference in mortality risk between the surgical and percutaneous revascularization groups [hazard ratio (HR) 1.23, 95% confidence interval (CI) 0.5-3.04; P = 0.649], whereas after 7 months, surgical revascularization was associated with a significant survival benefit (HR 2.24, 95% CI 1.03-4.87; P = 0.042). CONCLUSIONS: Our observation suggests that in a real-world setting, only approximately one-half of diabetic patients with multivessel disease are referred to surgical revascularization despite guideline indications. Surgical compared to percutaneous revascularization in this population was associated with improved long-term survival that became evident 7 months after the revascularization procedure.
引用
- Ram E, Goldenberg I, Sternik L, et al. Real-world referral pattern and outcomes of diabetic patients who undergo revascularization: data from the prospective Multi-vessel Coronary Artery Disease (MULTICAD) Israeli Registry†. Eur J Cardiothorac Surg. 2019. PMID: 30805588. doi:10.1093/ejcts/ezz050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。